The CD79A gene helps B cells, a type of immune cell, mature and recognize germs; if it does not work, your body may struggle to make antibodies and fight infections. In medicine, this gene is important because it helps regulate how B cells develop and respond after they detect an infection. People with two nonworking copies can develop an inherited antibody deficiency, often with very low B cells and repeated ear, sinus, or lung infections starting in infancy or childhood.
What is a gene?
Genes are sections of DNA that carry instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for building proteins, which are the working parts of cells. Others mainly regulate when, where, and how strongly certain processes take place. Taken together, genes influence how the body develops and functions, and they can shape your response to food, stress, or medications. For a deeper look at this topic, you can find more information in the LearnHub.
Overview
CD79AGene function
What if the gene works
The CD79A gene helps build part of the B cell receptor, a surface sensor on immune cells called B cells. This supports B cell development and helps these cells respond to germs.
Risk
What if the gene does not work
More disruptive variants in the CD79A gene often cause very low B cells and antibodies, leading to repeated bacterial infections from infancy. Milder variants may cause later or less severe antibody deficiency.
Treatment
What does that mean for your treatment
No CD79A-specific treatment or drug selection approach is currently established. Care for people with pathogenic variants in the CD79A gene usually follows standard management for agammaglobulinemia, such as immunoglobulin replacement and treatment of infections, rather than a medicine chosen because of the CD79A gene itself.
Conditions associated with CD79A
Gene function
What if the gene works
In immune cells called B cells, the CD79A gene helps the body spot germs and respond in a controlled way. It provides part of the B cell receptor, a surface sensor that lets B cells recognize targets. Understanding this everyday role helps explain what the CD79A gene does in immune cells during normal immune defense.
The CD79A gene helps assemble the B cell receptor on the surface of B cells. This receptor combines a target binding part with CD79A so the cell can detect germs and other foreign substances.
When a B cell receptor binds its target, the CD79A gene helps pass that message into the cell. This starts the internal signaling steps that guide normal B cell activity.
CD79A helps move the B cell receptor into the right place on the cell surface. With the receptor displayed properly, B cells can scan their surroundings for specific targets.
The CD79A gene supports the normal growth and training of B cells as they mature. This helps build a working group of immune cells that can take part in everyday defense.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change the function of a gene more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CD79A gene can weaken or shut down the CD79A protein, so the B cell receptor may not assemble or signal in developing B cells. More severe variants, such as those that cut the protein short or disrupt how the gene's message is pieced together, often leave little to no function. Smaller protein-changing variants may allow residual activity. With variants in both copies, this range can influence how early agammaglobulinemia appears and the degree of B cell loss.
How variants are linked to conditions
Two pathogenic variants in the CD79A gene cause a rare primary immunodeficiency called autosomal recessive agammaglobulinemia. In well-established reports on the CD79A gene and agammaglobulinemia, affected children have very low antibody levels and repeated infections, often beginning in infancy or early childhood. People carrying one variant usually do not develop the condition.
A variant is not necessarily a diagnosis
Variants are a usual feature of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CD79A-related illness, risk is mainly set by genetics, especially inheriting harmful changes in both copies of the CD79A gene. Family history can raise the chance of carrying these changes, but there are no well-established lifestyle or environmental factors known to meaningfully change the chance of having this condition.
Inheritance of CD79A variants
CD79A-related conditions are inherited in an autosomal recessive pattern. In practical terms, a child usually needs to inherit one changed copy of the CD79A gene from each parent to be affected. Parents who each carry one variant are usually unaffected themselves, and with each pregnancy there is a 25% chance the child will inherit both variants, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither variant. This CD79A inheritance pattern affects sons and daughters equally.
What does my CD79A result mean for my family?
For families with a disease-causing change in the CD79A gene, the pattern is usually recessive, so parents are often healthy carriers and brothers or sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of repeated serious infections in infancy or early childhood.
Genetic information
Genetic testing
How you find out about variants
To find out about changes linked to inherited immune problems, genetic testing for CD79A variants uses a blood sample, saliva, or cheek swab. A lab reads the DNA in the CD79A gene and compares it with the usual sequence to identify variants. Results may show a disease causing variant, a harmless variant, or a finding that is still unclear.
When should I consider getting a genetic test?
Consider testing the CD79A gene if someone has repeated serious infections from early life and blood tests show very low antibodies or very few B cells, which are infection-fighting immune cells. It can also help when a close relative has a known CD79A variant or a similar inherited immune condition.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and on the kind of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more quickly or more slowly, which can change how much of the medicine reaches the body and how long it stays active. This helps explain why the same treatment may work well for one person, seem less effective for another, or cause more side effects in someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in LearnHub.
Drugs influenced by the CD79A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or how well a treatment is working are best discussed with your doctor or pharmacist. Seek medical advice if a new medicine causes unusual symptoms or does not seem to help as expected.
History
CD79A entered the research literature in the late 1980s and early 1990s, when scientists studying B cells were trying to identify the proteins that make up the B cell receptor. It was first known as MB-1 before the standard name, the CD79A gene, became widely used. Early work showed that CD79A was closely linked with CD79B, helping clarify how this receptor complex was organized. From these first observations, research expanded steadily. As more families with inherited immune conditions were studied, variants in the CD79A gene were recognized as a cause of some forms of antibody deficiency. That discovery placed CD79A in the broader history of genes that helped explain why some people have repeated infections from early life.